R. Nave

883 total citations
41 papers, 722 citations indexed

About

R. Nave is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Reproductive Medicine. According to data from OpenAlex, R. Nave has authored 41 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 6 papers in Reproductive Medicine. Recurrent topics in R. Nave's work include Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (14 papers) and Inhalation and Respiratory Drug Delivery (12 papers). R. Nave is often cited by papers focused on Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (14 papers) and Inhalation and Respiratory Drug Delivery (12 papers). R. Nave collaborates with scholars based in Germany, Japan and United States. R. Nave's co-authors include Karl Zech, Hartmut Derendorf, Anton Drollmann, Franklin Cerasoli, W Wurst, Shashank Rohatagi, Rainer Fuhst, Vikram Arya, T.D. Bethke and Bradford K. Jensen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

R. Nave

40 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Nave Germany 14 449 443 109 65 47 41 722
Mun Su Chung South Korea 16 92 0.2× 201 0.5× 73 0.7× 43 0.7× 1 0.0× 44 579
Jerry Herron United States 14 276 0.6× 149 0.3× 220 2.0× 45 0.7× 20 573
Norihiro Saito Japan 15 314 0.7× 148 0.3× 81 0.7× 10 0.2× 5 0.1× 56 642
Vincent Gros France 14 721 1.6× 640 1.4× 238 2.2× 29 0.4× 40 849
W. Stricker United States 11 821 1.8× 652 1.5× 434 4.0× 33 0.5× 1 0.0× 14 1.0k
Ferda Öner Erkekol Türkiye 13 158 0.4× 67 0.2× 72 0.7× 19 0.3× 3 0.1× 43 476
Gregor Holzer Austria 10 114 0.3× 19 0.0× 43 0.4× 31 0.5× 6 0.1× 16 495
Bruce M. Prenner United States 22 1.1k 2.4× 490 1.1× 901 8.3× 49 0.8× 55 1.4k
N. Cester Italy 12 77 0.2× 70 0.2× 4 0.0× 151 2.3× 15 0.3× 46 476
So-Hee Lee South Korea 14 179 0.4× 137 0.3× 70 0.6× 11 0.2× 1 0.0× 33 407

Countries citing papers authored by R. Nave

Since Specialization
Citations

This map shows the geographic impact of R. Nave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nave more than expected).

Fields of papers citing papers by R. Nave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Nave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nave. The network helps show where R. Nave may publish in the future.

Co-authorship network of co-authors of R. Nave

This figure shows the co-authorship network connecting the top 25 collaborators of R. Nave. A scholar is included among the top collaborators of R. Nave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Nave. R. Nave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nave, R., et al.. (2017). The Effect of Drug Content Reduction on the In Vitro and In Vivo Properties of Levonorgestrel-Releasing Intravaginal Rings. Journal of Pharmaceutical Sciences. 107(4). 1020–1027. 6 indexed citations
2.
3.
Plock, Nele, et al.. (2013). An innovative Phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 495–508. 4 indexed citations
4.
Hartmann, M., Wolfgang Timmer, Armin Schultz, et al.. (2012). A Thorough QT Study of Teduglutide in Healthy Subjects. Clinical Pharmacology in Drug Development. 1(2). 57–66. 3 indexed citations
5.
Nave, R., et al.. (2012). Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study. International Journal of Clinical Pharmacology and Therapeutics. 50(10). 751–759. 5 indexed citations
6.
Nave, R., et al.. (2012). Population pharmacokinetic metaanalysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain. International Journal of Clinical Pharmacology and Therapeutics. 50(9). 665–677. 3 indexed citations
7.
Nave, R., Atef Halabi, Rolf Herzog, et al.. (2012). Pharmacokinetics of teduglutide in subjects with renal impairment. European Journal of Clinical Pharmacology. 69(5). 1149–1155. 16 indexed citations
8.
Xu, Jian, R. Nave, Gëzim Lahu, Eric Derom, & Hartmut Derendorf. (2010). Population Pharmacokinetics and Pharmacodynamics of Inhaled Ciclesonide and Fluticasone Propionate in Patients With Persistent Asthma. The Journal of Clinical Pharmacology. 50(10). 1118–1127. 14 indexed citations
9.
Nave, R., Henrik Watz, Hans Hoffmann, Hildegard Boss, & H Magnussen. (2010). Deposition and metabolism of inhaled ciclesonide in the human lung. European Respiratory Journal. 36(5). 1113–1119. 19 indexed citations
10.
Nave, R.. (2009). Clinical Pharmacokinetic and Pharmacodynamic Profile of Inhaled Ciclesonide. Clinical Pharmacokinetics. 48(4). 243–252. 24 indexed citations
11.
12.
Sato, Hiroaki, et al.. (2006). In vitro activation of the corticosteroid ciclesonide in animal nasal mucosal homogenates. Biopharmaceutics & Drug Disposition. 28(2). 59–64. 5 indexed citations
13.
Nave, R., Kulasiri A. Gunawardena, Karl Zech, & T.D. Bethke. (2006). Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar. International Journal of Clinical Pharmacology and Therapeutics. 44(1). 1–7. 20 indexed citations
14.
Derendorf, Hartmut, R. Nave, Anton Drollmann, Franklin Cerasoli, & W Wurst. (2006). Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. European Respiratory Journal. 28(5). 1042–1050. 188 indexed citations
15.
Wingertzahn, Mark A., et al.. (2005). Comparison of nasal tissue concentrations in rabbits following administration of hypotonic and isotonic ciclesonide suspensions. Journal of Allergy and Clinical Immunology. 115(2). S126–S126. 9 indexed citations
16.
Mascher, Daniel, et al.. (2005). Ultra-sensitive determination of Formoterol in human serum by high performance liquid chromatography and electrospray tandem mass spectrometry. Journal of Chromatography B. 830(1). 25–34. 9 indexed citations
17.
Nave, R., et al.. (2005). Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide. Pulmonary Pharmacology & Therapeutics. 18(6). 390–396. 69 indexed citations
18.
Drollmann, Anton, et al.. (2004). Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of a spacer for inhalation. Journal of Allergy and Clinical Immunology. 113(2). S120–S120. 5 indexed citations
19.
Nave, R., Karl Zech, & T.D. Bethke. (2003). Oropharyngeal deposition of inhaled ciclesonide and budesonide in healthy subjects. Journal of Allergy and Clinical Immunology. 111(2). S220–S220. 7 indexed citations
20.
Rohatagi, Shashank, Vikram Arya, Karl Zech, et al.. (2003). Population Pharmacokinetics and Pharmacodynamics of Ciclesonide. The Journal of Clinical Pharmacology. 43(4). 365–378. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mun Su Chung Breakdown of academic impact, for papers by Jerry Herron Breakdown of academic impact, for papers by Norihiro Saito Breakdown of academic impact, for papers by Vincent Gros Breakdown of academic impact, for papers by W. Stricker Breakdown of academic impact, for papers by Ferda Öner Erkekol Breakdown of academic impact, for papers by Gregor Holzer Breakdown of academic impact, for papers by Bruce M. Prenner Breakdown of academic impact, for papers by N. Cester Breakdown of academic impact, for papers by So-Hee Lee
Rankless by CCL
2026